D. ÖZATLI Et Al. , "BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, pp.163-168, 2010
ÖZATLI, D. Et Al. 2010. BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3 , 163-168.
ÖZATLI, D., Timuragaoglu, A., Alanoglu, G., Dizlek, S., & Uysalgil, N., (2010). BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, 163-168.
ÖZATLI, DÜZGÜN Et Al. "BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, 163-168, 2010
ÖZATLI, DÜZGÜN Et Al. "BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, pp.163-168, 2010
ÖZATLI, D. Et Al. (2010) . "BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.3, pp.163-168.
@article{article, author={DÜZGÜN ÖZATLI Et Al. }, title={BCR-ABL Transcript Level and Neutrophil Alkaline Phosphatase Activity in CML Patients Treated with Imatinib}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2010, pages={163-168} }